NEULAND LABORATORIES
Back to All Ratios
|
NEULAND LABORATORIES Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 355.22 | 253.82 | 280.42 | 168.59 | 87.97 |
What is the latest Cash Earnings per Share (CEPS) ratio of NEULAND LABORATORIES ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2026 | 355.22 |
| Mar2025 | 253.82 |
| Mar2024 | 280.42 |
| Mar2023 | 168.59 |
| Mar2022 | 87.97 |
How is Cash Earnings per Share (CEPS) of NEULAND LABORATORIES Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2026 | 355.22 | 39.95 | |
| Mar2025 | 253.82 | -9.49 | |
| Mar2024 | 280.42 | 66.33 | |
| Mar2023 | 168.59 | 91.64 | |
| Mar2022 | 87.97 | - | |
Other Financial Ratios of NEULAND LABORATORIES
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹24,689.0 Cr | -2.2% | 2.3% | 41.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -2.2% |
2.3% |
41.4% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses